News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
39,629 Results
Type
Article (3159)
Company Profile (7)
Press Release (36463)
Section
Business (10535)
Career Advice (182)
Deals (1598)
Drug Delivery (13)
Drug Development (7516)
Employer Resources (4)
FDA (1326)
Job Trends (1221)
News (21136)
Policy (2400)
Tag
Academia (267)
Accelerated approval (1)
Adcomms (4)
Allergies (11)
Alliances (2162)
ALS (15)
Alzheimer's disease (94)
Antibody-drug conjugate (ADC) (29)
Approvals (1334)
Artificial intelligence (19)
Autoimmune disease (10)
Bankruptcy (14)
Best Places to Work (1026)
Biosimilars (12)
Biotechnology (4)
Bladder cancer (11)
Brain cancer (6)
Breast cancer (60)
Cancer (379)
Cardiovascular disease (32)
Career advice (157)
Career pathing (3)
CAR-T (41)
CDC (7)
Cell therapy (83)
Cervical cancer (1)
Clinical research (6587)
Collaboration (54)
Company closure (1)
Compensation (73)
Complete response letters (1)
COVID-19 (311)
CRISPR (4)
C-suite (38)
Cystic fibrosis (9)
Data (490)
Decentralized trials (1)
Depression (10)
Diabetes (36)
Diagnostics (336)
Digital health (3)
Diversity (1)
Drug discovery (9)
Drug pricing (16)
Drug shortages (2)
Duchenne muscular dystrophy (28)
Earnings (4555)
Editorial (4)
Employer branding (1)
Employer resources (6)
Events (4811)
Executive appointments (47)
FDA (1598)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (69)
Gene editing (14)
Generative AI (1)
Gene therapy (70)
GLP-1 (90)
Government (532)
Grass and pollen (1)
Guidances (24)
Healthcare (1323)
HIV (5)
Huntington's disease (3)
IgA nephropathy (1)
Immunology and inflammation (12)
Immuno-oncology (5)
Indications (6)
Infectious disease (332)
Inflammatory bowel disease (5)
Inflation Reduction Act (4)
Influenza (3)
Intellectual property (11)
Interviews (36)
IPO (799)
IRA (4)
Job creations (221)
Job search strategy (129)
JPM (6)
Labor market (10)
Layoffs (28)
Leadership (3)
Legal (375)
Liver cancer (13)
Lung cancer (52)
Lymphoma (41)
Machine learning (2)
Management (3)
Manufacturing (32)
MASH (10)
Medical device (625)
Medtech (629)
Mergers & acquisitions (831)
Metabolic disorders (87)
Multiple sclerosis (9)
NASH (1)
Neurodegenerative disease (22)
Neuropsychiatric disorders (8)
Neuroscience (176)
NextGen: Class of 2026 (493)
Non-profit (416)
Now hiring (10)
Obesity (43)
Opinion (24)
Ovarian cancer (14)
Pain (12)
Pancreatic cancer (31)
Parkinson's disease (16)
Partnered (2)
Patents (18)
Patient recruitment (24)
Peanut (4)
People (3280)
Pharmaceutical (1)
Pharmacy benefit managers (2)
Phase 1 (2131)
Phase 2 (2914)
Phase 3 (2152)
Pipeline (339)
Policy (23)
Postmarket research (287)
Preclinical (435)
Press Release (2)
Prostate cancer (13)
Psychedelics (6)
Radiopharmaceuticals (9)
Rare diseases (64)
Real estate (343)
Recruiting (3)
Regulatory (1813)
Reports (2)
Research institute (206)
Resumes & cover letters (20)
Rett syndrome (1)
RSV (4)
Schizophrenia (11)
Series A (11)
Series B (6)
Sickle cell disease (7)
Special edition (1)
Spinal muscular atrophy (23)
Sponsored (1)
Startups (197)
Stomach cancer (3)
Supply chain (2)
Tariffs (5)
The Weekly (7)
Vaccines (110)
Venture capital (7)
Weight loss (28)
Women's health (3)
Worklife (1)
Date
Today (10)
Last 7 days (43)
Last 30 days (99)
Last 365 days (1615)
2026 (159)
2025 (1635)
2024 (1861)
2023 (2149)
2022 (2837)
2021 (3172)
2020 (3177)
2019 (3258)
2018 (2429)
2017 (2059)
2016 (1986)
2015 (2284)
2014 (1640)
2013 (1246)
2012 (1387)
2011 (1482)
2010 (1160)
Location
Africa (76)
Alabama (2)
Alaska (1)
Arizona (33)
Asia (2389)
Australia (354)
California (472)
Canada (205)
China (62)
Colorado (24)
Connecticut (19)
Delaware (27)
Europe (5747)
Florida (57)
Georgia (17)
Idaho (2)
Illinois (59)
India (6)
Indiana (35)
Iowa (2)
Japan (50)
Kansas (11)
Kentucky (2)
Louisiana (2)
Maine (5)
Maryland (59)
Massachusetts (369)
Michigan (6)
Minnesota (32)
Missouri (5)
Montana (2)
Nebraska (2)
Nevada (3)
New Hampshire (1)
New Jersey (255)
New York (151)
North Carolina (63)
Northern California (263)
Ohio (13)
Oklahoma (1)
Oregon (4)
Pennsylvania (119)
Puerto Rico (1)
Rhode Island (3)
South America (74)
South Carolina (3)
Southern California (160)
Tennessee (10)
Texas (103)
United States (1964)
Utah (7)
Virginia (11)
Washington D.C. (2)
Washington State (37)
West Virginia (1)
Wisconsin (6)
39,629 Results for "twentyeight seven therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Akeso’s IL-4Rα/ST2 Bispecific Antibody Cleared for Seven Phase II Studies in China Spanning Respiratory and Autoimmune Indications
February 11, 2026
·
5 min read
Alzheimer’s disease
Roche’s Next-Gen Alzheimer’s Antibody Clears or Reduces Amyloid Plaques in Seven Months
In a Phase Ib/IIa trial, 91% of patients receiving the highest dose of trontinemab were amyloid negative after seven months of treatment, representing what B. Riley Securities called a “paradigm shift” to first-generation FDA-approved antibodies.
July 28, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
National Organization for Rare Disorders Adds Seven Rare Disease Centers of Excellence Nationwide
December 4, 2025
·
3 min read
Drug Development
Basilea announces sale of preclinical oncology program to Twentyeight-Seven Therapeutics
Basilea Pharmaceutica Ltd. announced that it has entered into an asset purchase agreement with Twentyeight-Seven Therapeutics, Inc. for novel inhibitors of CLK kinases, developed by Basilea, that target aberrant splicing of RNA in cancer.
November 2, 2022
·
3 min read
Press Releases
BostonGene to Present Seven Studies Unveiling Novel AI-Driven Breast Cancer Breakthroughs at SABCS 2025
December 9, 2025
·
6 min read
Press Releases
Konica Minolta Healthcare Reinforces Leadership in Advanced Radiography with Seven Scientific Presentations on Dynamic Digital Radiography at RSNA 2025
November 21, 2025
·
7 min read
Press Releases
Imviva Biotech Announces Seven Presentations Highlighting its ANSWER™ Allogeneic CAR-T Platform at the 67th American Society of Hematology Annual Meeting
November 24, 2025
·
6 min read
CDC
ACIP Revamp Continues as Kennedy Eyes Seven New CDC Vaccine Advisors
The new additions would bring ACIP membership to 14 total. Several of the proposed members have taken part in anti-vaccine activity or made anti-vaccine statements.
September 4, 2025
·
2 min read
·
Dan Samorodnitsky
Job Trends
BioSpace
Reveals Fresh Design With 2026 Hotbed Maps, Highlighting Life Sciences Hubs
BioSpace
has revealed its new 2026 Hotbed Maps, showcasing seven regional life sciences hot spots.
January 20, 2026
·
2 min read
·
Chantal Dresner
Press Releases
Libtayo® (cemiplimab for injection) Now Reimbursed in Seven Provinces for Advanced Non-Small Cell Lung Cancer and Locally Advanced Basal Cell Carcinoma
October 31, 2025
·
7 min read
1 of 3,963
Next
